𝔖 Bobbio Scriptorium

✦ LIBER ✦

A five-year follow-up study of Dukes’ B colonic cancer: Does adjuvant chemotherapy alter survival?

✍ Scribed by Rhiannon Harries; W. Al-Khyatt; A. Brewster; K. Swarnkar; B. Stephenson; G. Williams

Book ID: 116444372
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 76 KB
Volume: 37
Category: Article
ISSN: 0748-7983
DOI: 10.1016/j.ejso.2011.08.032

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

299. A Five-year Follow-up Study of Duke

299. A Five-year Follow-up Study of Dukes’ B Colonic Cancer - Does Adjuvant Chemotherapy Alter Survival?

✍ Harries, R.L.; Al-Khyatt, W.; Brewster, A.E.; Swarnkar, K.J.; Mckain, E.S.; Step 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Changing Patterns of Prognosticators Dur

Changing Patterns of Prognosticators During 15-Year Follow-Up of Advanced Gastric Cancer after Radical Gastrectomy and Adjuvant Chemotherapy: A 15-Year Follow-Up Study at a Single Korean Institute

✍ Yong Wha Moon; Hei-Cheul Jeung; Sun Young Rha; Nae Choon Yoo; Jae Kyung Roh; Sun 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 309 KB

Randomized trial of adjuvant chemotherap

Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up

✍ Neri, B; Cini, G; Andreoli, F; Boffi, B; Francesconi, D; Mazzanti, R; Medi, F; M 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 54 KB

10-year follow-up update of French adjuv

10-year follow-up update of French adjuvant study group 05 trial: FEC 100 regimen remains superior to FEC 50 in adjuvant chemotherapy of poor prognosis, node-positive, early breast cancer patients

✍ V. Servent; J. Bonneterre; H. Roché; P. Kerbrat; A. Brémond; P. Fumoleau; M. Nam 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 192 KB

417 Biochemical disease-free and overall

417 Biochemical disease-free and overall survival of treatments for localized prostate cancer: Cohort study with a 7 year follow-up

✍ Bonet, X.; Suárez, J.F.; Castells, M.; Vicéns, A.J.; Franco, E.; Guedea, F.; De 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Four-Year Follow-Up of Trastuzumab Plus

Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31

✍ Perez, E. A.; Romond, E. H.; Suman, V. J.; Jeong, J.-H.; Davidson, N. E.; Geyer, 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 257 KB